Globus Medical GMED shares soared 5.4%
Globus Medical GMED shares soared 5.4% within the final buying and selling session to shut at $73.37. The transfer was backed by strong quantity with way more shares altering fingers than in a traditional session. This compares to the inventory’s 9.2% achieve over the previous 4 weeks.
Globus Medical recorded a powerful worth enhance pushed by its encouraging first-quarter 2021 outcomes, with adjusted earnings per share and revenues surpassing Zacks Consensus Estimate by 36.1% and 15%, respectively. The raised full yr 2021 steerage additionally augers properly. The corporate’s strong product suite, which incorporates the CORBEL Lateral ALIF system and CREO ONE, and a powerful robotics arm driving the highest line through the first quarter elevate optimism.
Value and Consensus
This medical machine firm is predicted to publish quarterly earnings of $0.42 per share in its upcoming report, which represents a year-over-year change of +500%. Revenues are anticipated to be $211.71 million, up 42.2% from the year-ago quarter.
Whereas earnings and income development expectations are vital in evaluating the potential power in a inventory, empirical analysis exhibits a powerful correlation between tendencies in earnings estimate revisions and near-term inventory worth actions.
For Globus Medical, the consensus EPS estimate for the quarter has been revised marginally decrease during the last 30 days to the present degree. And a adverse development in earnings estimate revisions does not normally translate into worth appreciation. So, be sure that to regulate GMED going ahead to see if this latest bounce can flip into extra power down the street.
The inventory presently carries a Zacks Rank 2 (Purchase). You’ll be able to see the whole record of right this moment’s Zacks Rank #1 (Sturdy Purchase) shares right here >>>>
Need the most recent suggestions from Zacks Funding Analysis? Immediately, you’ll be able to obtain 7 Finest Shares for the Subsequent 30 Days. Click on to get this free report
Globus Medical, Inc. (GMED): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.